HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hiroshi Goto Selected Research

Retinal Detachment (Retinal Detachments)

1/2022Clinical Characteristics, Management, and Factors Associated with Poor Visual Prognosis of Acute Retinal Necrosis.
3/2017EFFICACY OF THE INVERTED INTERNAL LIMITING MEMBRANE FLAP TECHNIQUE WITH VITRECTOMY FOR RETINAL DETACHMENT ASSOCIATED WITH MYOPIC MACULAR HOLES.
1/2015Development and validation of new diagnostic criteria for acute retinal necrosis.
1/2013Acute retinal necrosis: factors associated with anatomic and visual outcomes.
4/2010[Pars plana vitrectomy in patients with acute retinal necrosis syndrome: surgical results in 52 patients].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hiroshi Goto Research Topics

Disease

35Uveitis
11/2023 - 06/2003
29Neoplasms (Cancer)
01/2023 - 06/2006
18Inflammation (Inflammations)
11/2023 - 02/2005
16Macular Edema
04/2024 - 04/2011
11Sarcoidosis (Schaumann Disease)
12/2023 - 06/2008
11Uveomeningoencephalitic Syndrome (Vogt Koyanagi Harada Syndrome)
08/2023 - 07/2006
10Neoplasm Metastasis (Metastasis)
09/2020 - 11/2002
9Retinal Vein Occlusion
04/2024 - 04/2011
9Cataract (Cataracts)
03/2022 - 04/2005
9Diabetic Retinopathy (Retinopathy, Diabetic)
01/2019 - 02/2010
7Lymphoma (Lymphomas)
12/2023 - 06/2017
7Macular Degeneration (Age-Related Maculopathy)
01/2022 - 09/2014
7Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
01/2021 - 12/2006
6Behcet Syndrome (Behcet's Syndrome)
11/2023 - 06/2008
6Retinal Perforations
01/2022 - 01/2011
6Hemorrhage
01/2021 - 11/2005
6Keratitis
01/2019 - 05/2013
6Optic Neuritis (Retrobulbar Neuritis)
10/2015 - 01/2011
5Retinal Vasculitis
11/2023 - 07/2005
5Acute Retinal Necrosis Syndrome
06/2023 - 06/2006
5Panuveitis
06/2022 - 01/2018
5Glaucoma
01/2022 - 09/2009
5Retinal Detachment (Retinal Detachments)
01/2022 - 04/2010
5Lymphoproliferative Disorders (Lymphoproliferative Disorder)
04/2021 - 12/2006
4Necrosis
11/2023 - 06/2006
4Vitreous Hemorrhage
01/2021 - 09/2012
4Melanoma (Melanoma, Malignant)
05/2017 - 08/2007
4Uveal melanoma
02/2017 - 04/2004
4Multiple Sclerosis
10/2015 - 01/2011
3Infections
01/2023 - 06/2014
3Epiretinal Membrane (Epiretinal Membranes)
11/2022 - 08/2012
3Rectal Neoplasms (Rectal Cancer)
11/2017 - 11/2009
3Choroidal Neovascularization
10/2015 - 07/2009
3Retinal Degeneration
10/2015 - 08/2011
3Polypoidal Choroidal Vasculopathy
05/2015 - 01/2012
3Intraocular Lymphoma
07/2012 - 03/2006
3Hypersensitivity (Allergy)
04/2009 - 02/2003
2Edema (Dropsy)
06/2022 - 07/2005
2Disease Progression
01/2022 - 02/2003
2Optic Atrophy
01/2022 - 01/2015
2Immunoglobulin G4-Related Disease
05/2021 - 01/2018
2Posterior Uveitis
01/2021 - 01/2019
2Intermediate Uveitis (Chronic Cyclitis)
01/2021 - 01/2019
2Retinitis
05/2020 - 07/2008
2Pancreatic Neoplasms (Pancreatic Cancer)
12/2019 - 11/2014

Drug/Important Bio-Agent (IBA)

25Retinaldehyde (Retinal)IBA
04/2024 - 02/2005
18Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021 - 07/2009
14Ranibizumab (Lucentis)FDA Link
04/2024 - 01/2012
14CytokinesIBA
01/2021 - 04/2009
11Proteins (Proteins, Gene)FDA Link
12/2023 - 11/2004
11Adrenal Cortex Hormones (Corticosteroids)IBA
07/2022 - 07/2006
9Adalimumab (Humira)FDA Link
10/2022 - 01/2018
9Interleukin-8 (Interleukin 8)IBA
01/2021 - 01/2008
5Infliximab (Remicade)FDA Link
01/2023 - 05/2012
5Biomarkers (Surrogate Marker)IBA
06/2022 - 02/2017
5Interferon-gamma (Interferon, gamma)IBA
09/2014 - 02/2007
4Fluorescein (Funduscein)FDA LinkGeneric
11/2023 - 07/2005
4A-factor (Streptomyces)IBA
11/2022 - 04/2005
4S100 Proteins (S 100 Protein)IBA
09/2021 - 11/2006
4Immunoglobulin G (IgG)IBA
05/2021 - 02/2003
4InterferonsIBA
01/2021 - 02/2010
4Bevacizumab (Avastin)FDA Link
01/2019 - 11/2010
4Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
01/2017 - 02/2010
4Interleukin-10 (Interleukin 10)IBA
05/2014 - 10/2010
3AntigensIBA
01/2023 - 06/2010
3Monoclonal AntibodiesIBA
01/2023 - 03/2012
3EnzymesIBA
06/2022 - 12/2006
3Immunoglobulins (Immunoglobulin)IBA
06/2022 - 10/2016
3Prednisolone (Predate)FDA LinkGeneric
03/2022 - 05/2014
3Melanins (Melanin)IBA
01/2022 - 01/2017
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
09/2021 - 01/2018
3Interleukin-6 (Interleukin 6)IBA
01/2021 - 06/2010
3angiogeninIBA
01/2021 - 09/2014
3MicroRNAs (MicroRNA)IBA
08/2020 - 01/2020
3Ophthalmic Solutions (Eye Drops)IBA
01/2019 - 06/2014
3Levofloxacin (Levaquin)FDA Link
01/2019 - 06/2014
3afliberceptIBA
05/2018 - 01/2013
3DNA (Deoxyribonucleic Acid)IBA
11/2016 - 12/2006
3ChemokinesIBA
03/2012 - 02/2010
2SteroidsIBA
08/2023 - 08/2019
2Anti-Bacterial Agents (Antibiotics)IBA
01/2023 - 05/2013
2ImmunosorbentsIBA
06/2022 - 06/2008
2MART-1 AntigenIBA
09/2021 - 05/2017
2Methotrexate (Mexate)FDA LinkGeneric
04/2021 - 05/2020
2Indicators and Reagents (Reagents)IBA
01/2021 - 01/2019
2InterleukinsIBA
01/2021 - 01/2017
2RNA (Ribonucleic Acid)IBA
10/2020 - 10/2015
2Antiviral Agents (Antivirals)IBA
05/2020 - 01/2015
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2019 - 02/2008

Therapy/Procedure

28Therapeutics
11/2023 - 07/2009
20Vitrectomy
11/2022 - 04/2010
11Drug Therapy (Chemotherapy)
06/2023 - 11/2002
7Radiotherapy
06/2017 - 11/2002
6Slit Lamp
02/2015 - 02/2007
4Aftercare (After-Treatment)
11/2023 - 05/2015
3Light Coagulation
01/2023 - 11/2002
3Intravitreal Injections
08/2015 - 02/2005
2Trabeculectomy (Trabeculoplasty)
11/2021 - 01/2019
2Transplantation
06/2021 - 06/2006
2Injections
05/2020 - 01/2019